96 related articles for article (PubMed ID: 17681599)
21. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
Iriyama N; Takahashi H; Naruse H; Miura K; Uchino Y; Nakagawa M; Iizuka K; Hamada T; Hatta Y; Nakayama T; Takei M
Mol Genet Genomic Med; 2019 Apr; 7(4):e00591. PubMed ID: 30697976
[TBL] [Abstract][Full Text] [Related]
22. NUP98-NSD1 fusion by insertion in acute myeloblastic leukemia.
Petit A; Radford I; Waill MC; Romana S; Berger R
Cancer Genet Cytogenet; 2008 Jan; 180(1):43-6. PubMed ID: 18068532
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
24. [Hypereosinophilic syndrome--difficult-to-catch diagnosis. Targeted molecular diagnostics and treatment now possible thanks to gene discovery].
Jönsson S; Lewerin C; Jacobsson S; Wadenvik H
Lakartidningen; 2006 Sep 6-12; 103(36):2556-9. PubMed ID: 17007200
[No Abstract] [Full Text] [Related]
25. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
[TBL] [Abstract][Full Text] [Related]
26. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
Chien JH; Tang JL; Chen RL; Li CC; Lee CP
Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
[TBL] [Abstract][Full Text] [Related]
28. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
29. A case of chronic myelogenous leukemia with e8a2 fusion transcript.
Park IJ; Lim YA; Lee WG; Park JS; Kim HC; Lee HJ; Cho SR
Cancer Genet Cytogenet; 2008 Sep; 185(2):106-8. PubMed ID: 18722880
[TBL] [Abstract][Full Text] [Related]
30. Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia.
Arancibia AM; Bendit I; Epelman S
Pediatr Blood Cancer; 2008 May; 50(5):1078. PubMed ID: 18085674
[No Abstract] [Full Text] [Related]
31. Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions.
Cerveira N; Micci F; Santos J; Pinheiro M; Correia C; Lisboa S; Bizarro S; Norton L; Glomstein A; Asberg AE; Heim S; Teixeira MR
Haematologica; 2008 Jul; 93(7):1076-80. PubMed ID: 18492691
[TBL] [Abstract][Full Text] [Related]
32. Chronic eosinophilic leukemia with a unique translocation.
Arora RS
Indian Pediatr; 2009 Jun; 46(6):525-7. PubMed ID: 19556663
[TBL] [Abstract][Full Text] [Related]
33. Hypereosinophilic syndrome, chronic eosinophilic leukemia, and mast cell disease.
Pardanani A; Verstovsek S
Cancer J; 2007; 13(6):384-91. PubMed ID: 18032976
[TBL] [Abstract][Full Text] [Related]
34. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
[TBL] [Abstract][Full Text] [Related]
35. Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13).
Shin J; Kim M; Kim DB; Yeom JO; Lee HJ; Cho SG
Acta Haematol; 2008; 119(1):57-9. PubMed ID: 18268406
[No Abstract] [Full Text] [Related]
36. Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients.
Bianchini M; De Brasi C; Gargallo P; Gonzalez M; Bengió R; Larripa I
Eur J Haematol; 2009 Apr; 82(4):292-300. PubMed ID: 19191867
[TBL] [Abstract][Full Text] [Related]
37. [Chronic eosinophilic leukemia with complex karyotypic abnormalities including trisomy 8].
Wakabayashi S; Yamamoto K; Arai A; Miura O
Rinsho Ketsueki; 2008 Jul; 49(7):510-5. PubMed ID: 18709984
[TBL] [Abstract][Full Text] [Related]
38. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
[TBL] [Abstract][Full Text] [Related]
39. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.
Taketani T; Taki T; Sako M; Ishii T; Yamaguchi S; Hayashi Y
Cancer Genet Cytogenet; 2008 Oct; 186(2):115-9. PubMed ID: 18940475
[TBL] [Abstract][Full Text] [Related]
40. Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia.
Mattarucchi E; Guerini V; Rambaldi A; Campiotti L; Venco A; Pasquali F; Lo Curto F; Porta G
Genes Chromosomes Cancer; 2008 Jul; 47(7):625-32. PubMed ID: 18398823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
